team in
charge may have decided against the potential benefits of an intravitreal
injection it is at least not recorded as such. Subconjunctival antibiotics ... chocolate agar 37c, sabrouds dextrose agar 25c, anaerobic blood
agar.
Treatment:
Intravitreal vancomycin 1
mg + ceftazidime 2.25 mg + dexamethazone 0.4 mg
Subconjunctival vancomycin
letter dated 04.09.2009 repudiated the claim on the ground that intravitreal injection of Lucentis
is not payable as per NIA circular dated 19.02.2009. The Respondent ... subsequent occasions by concerned doctors to undergo
similar treatment of intravitreal injection of Lucentis and incurred expenses worth
Principal Investigators of their trial sites are well experienced
to administer the intravitreal drug. (Copy enclosed) and not stated any word about the co investigator
doctors. Conjunctival smear and vitreous tap was taken and microbiological evaluation done. Intravitreal vancomycin and amikacin were administered along with fortified tobramycine eye drop, fortified
opinion that so far as the management of
the hyphema or intravitreal hemorrhage is concerned, standard line
of management is complete bed rest with head
complainant for having undergone treatment at Giridhar Institute for administration of intravitreal for choroidal neovascular membrane. He has incurred
